Clinical outcomes of direct oral anticoagulant off-label dosing in nonvalvular atrial fibrillation

Clinical outcomes of direct oral anticoagulant off-label dosing in nonvalvular atrial fibrillation

Introduction: Direct oral anticoagulants (DOACs) used in nonvalvular atrial fibrillation (NVAF) are superior or non-inferior to warfarin in reducing the risk of stroke while at the same time having a similar or lower risk of bleeding. However, reduced doses are prescribed more often than expected fr...

Full description

Saved in:
Bibliographic Details
Main Authors: M. Jansson, S. Själander, V. Sjögren, F. Björck, H. Renlund, A. Själander
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Thrombosis Update
Subjects:
Dabigatran
Rivaroxaban
Treatment outcome
Apixaban
Warfarin
Anticoagulants
Online Access:http://www.sciencedirect.com/science/article/pii/S2666572725000136
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

http://www.sciencedirect.com/science/article/pii/S2666572725000136

Similar Items